- Home
- ALOT vs MCRB Comparison
ALOT vs MCRB Comparison
Compare ALOT & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALOT
- MCRB
- Stock Information
- Founded
- ALOT 1969
- MCRB 2010
- Country
- ALOT United States
- MCRB United States
- Employees
- ALOT N/A
- MCRB N/A
- Industry
- ALOT Computer peripheral equipment
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- ALOT Technology
- MCRB Health Care
- Exchange
- ALOT Nasdaq
- MCRB Nasdaq
- Market Cap
- ALOT 114.8M
- MCRB 131.0M
- IPO Year
- ALOT N/A
- MCRB 2015
- Fundamental
- Price
- ALOT $12.62
- MCRB $0.73
- Analyst Decision
- ALOT
- MCRB Buy
- Analyst Count
- ALOT 0
- MCRB 4
- Target Price
- ALOT N/A
- MCRB $5.63
- AVG Volume (30 Days)
- ALOT 12.7K
- MCRB 2.0M
- Earning Date
- ALOT 12-12-2024
- MCRB 03-04-2025
- Dividend Yield
- ALOT N/A
- MCRB N/A
- EPS Growth
- ALOT 12.82
- MCRB N/A
- EPS
- ALOT 0.51
- MCRB N/A
- Revenue
- ALOT $153,515,000.00
- MCRB $126,325,000.00
- Revenue This Year
- ALOT N/A
- MCRB N/A
- Revenue Next Year
- ALOT N/A
- MCRB N/A
- P/E Ratio
- ALOT $23.82
- MCRB N/A
- Revenue Growth
- ALOT 3.48
- MCRB 12856.41
- 52 Week Low
- ALOT $11.00
- MCRB $0.54
- 52 Week High
- ALOT $18.25
- MCRB $1.53
- Technical
- Relative Strength Index (RSI)
- ALOT 48.69
- MCRB 37.88
- Support Level
- ALOT $12.00
- MCRB $0.71
- Resistance Level
- ALOT $13.38
- MCRB $0.91
- Average True Range (ATR)
- ALOT 0.53
- MCRB 0.06
- MACD
- ALOT 0.11
- MCRB -0.02
- Stochastic Oscillator
- ALOT 68.07
- MCRB 8.37
About ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.